Sort   by:  
 Page size 

Clavulanic acid (CA) is the preferred clinical drug for the treatment of infections by β-lactam antibiotic-resistant bacteria. CA is produced by Streptomyces clavuligerus, and although there have been many reports on the effects of carbon and nitrogen sources on CA production, the mechan...

2022-12-08 | MTBLS5744 | MetaboLights
Clavulanic acid is a clinically-important secondary metabolite used in treatment of infectious diseases. We aimed to decipher complex regulatory mechanisms acting in clavulanic acid biosynthesis through the analysis of transcriptome- and proteome-wide alterations in an industrial clavulanic acid ove...
ORGANISM(S): Streptomyces clavuligerus 
2022-11-02 | PXD032272 | Pride
Clavulanic acid (CLV) is a betalactam (BL) which inhibits betalactamases activity and is frequently administered combined with amoxicillin (AX). Both BLs can be independently involved in allergic reactions. Indeed, selective immediate allergic reactions to CLV have recently been reported in 30% of p...
ORGANISM(S): Homo sapiens (Human) 
2021-09-09 | PXD021675 | Pride
Comparative genomics and metabolomics analyses of clavulanic acid producing Streptomyces species provides insight into specialized metabolism and evolution of beta-lactam biosynthetic gene clusters. Run a Scherzo column. Positive and negative ionisation mode. The first deposition contains RAW, mzM...
ORGANISM(S): Streptomyces Jumonjinensis (ncbitaxon:1945) Streptomyces Clavuligerus (ncbitaxon:1901) Streptomyces Katsurahamenas (ncbitaxon:329527) 
2019-05-21 | MSV000083835 | GNPS
RS07910/07915 TCS multipath regulates clavulanic acid metabolic pathways in Streptomyces clavuligerus F613-1
To investigate the function of organic nitrogen on clavulanic acid biosynthesis in Streptomyces clavuligerus, we established F613-1 strain cells cultured in MH fermentation medium and ML fermentation medium. We then performed gene expression profiling analysis using data obtained from RNA-seq of 2 d...
ORGANISM(S): Streptomyces clavuligerus 
2022-08-25 | GSE211765 | GEO
Streptomyces clavuligerus F613-1 produces a clinically important β-lactamase inhibitor, clavulanic acid (CA). The biosynthesis pathway of CA has been basically elucidated, however, the global regulation of CA biosynthesis remains unclear. In order to further elucidate the regulatory mechanism of cla...
ORGANISM(S): Streptomyces clavuligerus 
2018-08-30 | GSE119208 | GEO
Effect of organic nitrogen on gene expression of clavulanic acid biosynthesis in Streptomyces clavuligerus F613-1
Clavulanic acid producing Streptomyces species Genome sequencing
Sort   by:  
 Page size